9 drug(s) with this reaction
6,347 total reports
Circumstance Or Information Capable Of Leading To Medication Error has been reported as an adverse reaction across 9 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 6,347 adverse event reports mention circumstance or information capable of leading to medication error in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with circumstance or information capable of leading to medication error, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have circumstance or information capable of leading to medication error listed in their FDA adverse event reports, sorted by report count:
In addition to circumstance or information capable of leading to medication error, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
9 drug(s) manufactured by Amgen Inc have circumstance or information capable of leading to medication error listed in their FDA adverse event reports: DENOSUMAB, DARBEPOETIN ALFA, ERENUMAB-AOOE, PEGFILGRASTIM, EPOETIN ALFA, and others.
There are a combined 6,347 reports of circumstance or information capable of leading to medication error across 9 Amgen Inc drug(s) in the FDA adverse event database.